跳到主要内容
Learn Motion
探索课程产品能力价格

下载 Learn Motion

用手机扫描二维码,下载 App。

App Store

扫码从 App Store 下载 Learn Motion打开商店页面

Google Play

扫码从 Google Play 下载 Learn Motion打开商店页面
登录
Learn Motion

How AI Uses DNA to Find New Medicines

1Why DNA Matters for Finding Medicines2Turning DNA Into Data a Computer Can Read3How AI Learns Patterns in DNA4From DNA Patterns to Disease Clues5From Target to Candidate Medicine6What AI Can and Cannot Do Here
From Target to Candidate Medicine

The Long Road From Target to Medicine

4 / 4
Here the whole journey is laid out as one ordered path, from a validated target on the left to an approved medicine on the right. Target validation comes first and can take a year or more — and this is where some targets are abandoned. Then the search for molecules: screening and optimization, several years, narrowing many candidates down to a single lead. Safety testing in laboratory systems and animals follows, roughly one to three years, to catch what predictions missed. Clinical trials come next in three phases — a small group for safety, a larger group to see whether it helps, a still larger group to confirm the benefit — together usually six to ten years. Regulators review last. Notice the faded branches falling away along the way: most candidates never reach the end, and the full road commonly takes ten to fifteen years.
0:00 / 0:00

The path from a validated target to an approved medicine is long, and most candidates that enter it do not finish. The stages below are the usual shape of that journey; the durations are typical ranges rather than fixed numbers, and they vary widely by disease and by how much is already known.

Target validation comes first. Laboratory work establishes that changing the gene or protein actually alters the disease process and that doing so is tolerable. This stage can take a year or more, and it sometimes ends with the target being abandoned.

Next comes the search for molecules that act on the target — the screening and optimization work. Many candidates are made and tested, and the ones that bind well, avoid obvious safety problems, and can be delivered in the body are refined into a single lead candidate. This typically takes several years.

Before any testing in people, the candidate goes through safety testing in laboratory systems and animals. This stage exists to catch problems that predictions missed, and it takes roughly one to three years.

Clinical trials then test the candidate in people, in three broad phases: a small group to check safety and how the body handles the drug, a larger group to see whether it actually helps, and a still larger group to confirm the benefit and track less common side effects. Together these phases usually take six to ten years.

Finally, regulators review the evidence and decide whether the medicine can be approved and sold. Even after approval, monitoring continues, because rare side effects may only appear once very large numbers of people have taken the medicine. From start to finish, the whole road commonly takes ten to fifteen years.

上一页4 / 4下一页

Learn Motion

生成课程,认真学会。

运营方:Wuhan Daoyin Technology Co., Ltd.

联系我们: [email protected]
隐私政策用户服务协议

© 2026 Learn Motion